Relief Therapeutics Holding AG (RLFTF)

[tcm55]

Wow good find, did you read the rest of my detailed post with links to CT.gov and my reasonings; that IV trial is not same patient condition as EAP? Mild to moderate for that IV Trial while other Trials looked for sickest. Exclusion Criteria for IV CT stated many limitations on patient health.
Thats why my comment. Other Drug Trials I noted were seeking the sickest patients back then, while RLF IV was not. Still skewed, IMO. At that time DSMB allowed IV CT to continue after 30 patient review of safety/futility.
EAP was just granted then. They also in house partnered instead of selling for $2-4B as I suggested. I only have free shares after 9-30 and have not been convinced to buy more again. JMHFO and actions...
102nd patient on IV Trial review by DSMB is the same. JJ said review has 4 possible outcomes and hopes to have info 28 days from 102nd. 102nd review is Not on CT.gov.
Today pps drift after Topline data???
JJ said, in EAP the control patients most had underlying conditions. Also listen at ( 7+14+31 min).

IV Trial..."Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)"

Only data JJ can speak on is safety-futility, Not actual findings at the Trial. IMO. Outcome assessor and Investigator/Drs will do that at end of Trial. Big Pharma is stacked in FDA now, per Dr JJ, Paper he wrote for EUA is already done... All-IMO, from what was said, posted on CT.gov...